Assisted Reproductive Technology | Painted Clothes

Assisted reproductive technology (ART) encompasses a range of medical treatments designed to help individuals or couples conceive, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and egg donation. With over 8 million babies born worldwide using ART since the first successful IVF birth in 1978, this field has grown significantly, with the global ART market projected to reach $31.4 billion by 2026. However, ART also raises complex ethical, legal, and social questions, such as access inequality, the commodification of reproductive materials, and the psychological impacts on all parties involved. The history of ART is marked by pioneers like Robert Edwards and Patrick Steptoe, who developed IVF, and more recent advancements in genetic testing and embryo selection. As technology continues to advance, the future of ART holds promise for treating infertility but also necessitates ongoing discussions about regulation, consent, and the welfare of children born through these methods. The vibe around ART is highly polarized, reflecting both the hope it offers to many and the ethical dilemmas it poses, with a controversy spectrum that ranges from concerns about the exploitation of surrogates to debates over the morality of selective embryo implantation.